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High prevalence of the metabolic syndrome 
among newly diagnosed type 2 diabetes patients in Denmark
Few population-based data exist on the 
prevalence of the metabolic syndrome 
(MS) its components, and its association 
with subclinical inflammation and insulin 
resistance among patients newly diagnosed 
with type 2 diabetes (T2D).
89% of the newly diagnosed T2D patients 
have the MS, with 90% having elevated 
waist circumference, blood pressure and 
blood glucose, and <50% having elevated 
triglycerides and reduced HDL-cholesterol. 
In T2D patients with MS 
-    Elevated C-peptide levels are common* 
-    CRP levels are increased* 
-    the risk of previous cardiovascular disease is high* 
* as compared to non-MS patients.
We examined the MS according to the International Diabetes 
Federation (IDF) criteria from 2009 by linkage primary 
data (waist circumference, fasting blood glucose, and 
C-reactive protein (CRP)) with variables from the Danish 
Diabetes Database  for  Adults  (blood pressure  and  lipids) 
and  a  nationwide prescription database (antilipidemic, 
antihypertensive, and hypoglycemic drugs) as illustrated 
below.
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Table 2 
n=525 non-MS MS
Prevalence 
ratio
Waist circumference
≥94/80 cm
20
(34.5 %)
458
(98.1 %)
2.84 
(2.49-3.20)
Elevated fasting BG
≥5,5 mmol/L
52
(89.7 %)
465
(99.6 %)
1.11 
(1.02-1.20)
Elevated BP 
≥ 130/80 mmHg
32
(55.2 %)
441
(94.4 %)
1.71 
(1.48-1.94)
Increased TG 
≥1,7 mmol/L
2 
(3.4 %)
227
(48.6 %)
14.10 
(12.73-15.46)
Reduced HDL-chol. 
<1,0/1,3 mmol/L
0 
(0.0 %)
157
(33.6 %)
Table 1 non-MS MS
Newly diagnosed 
patients with T2D*
58
(11 %)
467
(89 %)
Table 3
n=525,      51,7% men
non-MS MS Source
Age 
year
61,5
(50-66)
60,0
(53-66)
DD2
BMI 24,7
(22,5-27,5)
31,63
(27,7-35,9)
DDDA
Waist circumference
cm
88
(76-94)
109
(99-118)
DD2
Fasting Bloodglucose        
mmol/L
6,58
(6,09-7,67)
7,16
(6,42-8,15)
DD2
Systolic BP 
mmHG
127
(120-140)
135
(125-145)
DDDA
Diastolic BP
mmHG
80
(71-85)
80
(75-89)
DDDA
HbA1c 
percent
6,80
(6,30-11,70)
7,10
(6,20-40,00)
DDDA
Total cholesterol 
mmol/L
4,25
(3.25-4.90)
4,50
(3,70-5,20)
DDDA
C-peptide 
pmol/L
389
(305-563)
719
(510-934)
DD2
CRP, 
   mg/L
1.20
(0.60-3.50)
2.40
(1.00-5.10)
DD2
Previous hospitalised with CVD 0 23.1% NRP
The number of patients in the DD2 cohort without (non) and with metabolic syndrome 
(MS) as defined by the International Diabetes Federation in 2009. *diagnosed after 1.1.2009
The number and (percent) of patients matching the criteria for the metabolic syndrome (MS) as 
defined by the International Diabetes Federation and the prevalence ration (95% confidence interval). 
Patient characteristics, numbers are median (quartile) and abbreviations are body mass index 
(BMI), bloodpressure (BP), C-reactive protein (CRP), The Danish Diabetes Database for Adults 
(DDDA), Danish Centre for Strategic Research in Type 2 Diabetes (DD2), and cardio vascular 
disease (CVD), The Danish National Registry of Patients (NRP).
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